According to the latest report by IMARC Group, titled “Medical Swabs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the global medical swabs market size reached US$ 3.0 Billion in 2022.
Medical swabs are soft, thin, and elongated devices with a sterile tip used to collect samples from various body parts, such as the throat, nose, and ears. They are manufactured using several lightweight, flexible, and highly absorbent raw materials, such as cotton, nylon, rayon, polyester, foam, calcium alginate, and plastic. Medical swabs are widely used for microbiological testing, deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) sequencing, wound care, medical instrument cleaning, and topical applications. They are safe, cost-effective, versatile, durable, non-reactive, easy to store, and user-friendly products. They aid in preventing infections, reducing cross-contaminations, and improving the accuracy of medical diagnoses and treatments.
Medical Swabs Market Trends:
The rising demand for rapid testing due to the increasing prevalence of infectious diseases is one of the key factors driving the market growth. Medical swabs are widely used to collect samples from the nose, throat, and other body parts to identify pathogens associated with various infectious diseases, such as coronavirus (COVID-19), flu, influenza, strep throat, sexually transmitted infections, and respiratory syncytial virus (RSV). Furthermore, the widespread product utilization in various diagnostic procedures, such as genetic testing, cancer screening, and allergy testing, due to the increasing awareness regarding preventive healthcare, is providing an impetus to the market growth. In addition to this, the rising prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular diseases (CVDs), is acting as another growth-inducing factor. Additionally, the introduction of biodegradable products that are cost-effective, eco-friendly, and manufactured using various organic raw materials, such as bamboo, corn starch, and natural fibers, is positively influencing the market growth. Apart from this, the recent development of self-collecting swabs that allow users to collect their own samples, which, in turn, enhances convenience, maintains privacy, increases comfort, and reduces exposure to diseases, is favoring the market growth. Moreover, increasing product demand in veterinary care for applying medications, treating wounds, and collecting samples for disease diagnosis is propelling the market growth. Other factors, including rising adoption of point-of-care (POC) testing, increasing investment in the research and development (R&D) of innovative products, and significant growth in the healthcare and biopharmaceutical industries, are anticipated to drive the market growth. On account of the aforementioned factors, the market value is expected to reach US$ 3.7 Billion by 2028, exhibiting a CAGR of 4.6% during 2023-2028.
- On the basis of the product, the market has been divided into cotton tipped, foam tipped, non-woven, and others.
- Based on the sample type, the market has been classified into nasal, oral, and others.
- On the basis of application, the market has been divided into specimen collection, disinfection, and others.
- Based on the end user, the market has been classified into hospitals and clinics, laboratories and diagnostic centers, research institutes, and others.
- On a regional basis, the market has been categorized into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others), Latin America (Brazil, Mexico, and Others), and Middle East and Africa.
- The competitive landscape of the industry has also been examined, with some of the key players being 3M Company, ABclonal Inc, Advin Health Care, Anhui Jiaxin Medical Products Co. Ltd., Becton Dickinson and Company, Copan Diagnostics Inc., Dynarex Corporation, F.L. Medical S.r.l., GPC Medical Ltd., Poly Medicure Ltd. and Puritan Medical Products.
|Base Year of the Analysis
||Product, Sample Type, Application, End User, Region
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||3M Company, ABclonal Inc, Advin Health Care, Anhui Jiaxin Medical Products Co. Ltd., Becton Dickinson and Company, Copan Diagnostics Inc., Dynarex Corporation, F.L. Medical S.r.l., GPC Medical Ltd., Poly Medicure Ltd. and Puritan Medical Products.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800